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Eighty-three percent of polyphosphoinositide-spe- 
cific phospholipase C activity was recovered in a cy- 
tosolic fraction after nitrogen cavitation of turkey 
erythrocytes. This activity has been purified approxi- 
mately 50,000-fold when compared to the starting cy- 
tosol with a yield of 1.7-5.0s. Sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis of the phospholi- 
pase C preparation revealed a major polypeptide of 
150 kDa. The specific activity of the purified enzyme 
was 6.7-14.0 rmol/min/mg of protein with phosphati- 
dylinositol4,5-bisphosphate or phosphatidylinositol4- 
phosphate as substrate. Phospholipase C activity was 
markedly dependent on the presence of Ca’+. The phos- 
pholipase C showed an acidic pH optimum (pH 4.0). At 
neutral pH, noncyclic inositol phosphates were the ma- 
jor products formed by the phospholipase C, while at 
pH 4.0, substantial formation of inositol 1:2-cyclic 
phosphate derivatives occurred. Properties of the pu- 
rified 150-kDa turkey erythrocyte phospholipase C 
were compared with the approximately 150-kDa phos- 
pholipase C-0 and -y isoenzymes previously purified 
from bovine brain (Ryu, S. H., Cho, K. S., Lee, K. Y., 
Suh, P. G., and Rhee, S. G. (1987) J, Biol. Chem. 262, 
12511-1251s). The turkey erythrocyte phospholipase 
C differed from the two mammalian phospholipases 
with respect to the effect of sodium cholate on the rate 
of polyphosphoinositide hydrolysis observed. More- 
over, when presented with dispersions of pure inositol 
lipids, phospholipases C-j3 and -y displayed comparable 
maximal rates of polyphosphoinositide and phosphati- 
dylinositol hydrolysis. By contrast, the turkey eryth- 
rocyte phospholipase C displays a marked preference 
for polyphosphoinositide substrates. 
The trans-plasma membrane signalling response to many 
extracellular stimuli involves activation of an inositol lipid- 
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specific PLC.’ Two hydrolysis products of this enzyme, ino- 
sitol 1,4,5-trisphosphate and sn-1,2-diacylglycerol act as sec- 
ond messengers, releasing intracellularly stored calcium and 
activating protein kinase C (1, 2). The established role of 
PLC in signal transduction has recently stimulated much 
progress in defining a family of PLC isoenzymes that consists 
of a minimum of five structurally and immunologically dis- 
tinct proteins (3-8). A nomenclature recently proposed by 
Rhee et al (9) terms these proteins PLC-(Y, -fi, -7, -6, and t 
with respective sizes determined by SDS-PAGE analysis of 
65, 150, 145, 85, and 85 kDa. The entire primary sequence of 
PLC-(Y, -/3, -y, and -6 has been determined by cDNA cloning 
(10-14). Although overall homology is low, PLC-0, -7, and -6 
contain two domains of significant sequence similarity, pos- 
sibly involved in catalysis. The isoenzymes share some com- 
mon properties. When assayed with substrates presented as 
components of phospholipid vesicles or of mixed phospholipid 
and detergent micelles, each isoenzyme displays dependence 
on calcium for activity and can hydrolyze all three inositol 
lipids. However, substrate selectivity is critically dependent 
on both the composition of the substrate preparation used 
and on the concentration of Ca*+ and pH of the assay medium. 
The polyphosphoinositides are better substrates for these 
enzymes than is phosphatidylinositol under physiologically 
relevant conditions of Ca” and pH. The molecular properties 
of members of the family of PLC isoenzymes identified to 
date recently have been reviewed by Rhee et al (9). 
The mechanism(s) by which extracellular signals increase 
intracellular PLC activity are not yet fully understood. G- 
proteins play established roles in the stimulatory and inhibi- 
tory coupling of cell surface receptors to adenylate cyclase 
and the regulation of cGMP phosphodiesterase by rhodopsin 
in retinal rod outer segments (Ref. 15). A substantial body of 
evidence supports the idea that a G-protein couples cell sur- 
face receptors to PLC (Ref. 16). This proposal does not 
exclude alternative regulatory mechanisms: certain growth 
factor receptors may modulate PLC activity through a re- 
’ The abbreviations used are: PLC, phospholipase C; G-protein, 
guanine nucleotide binding protein; SDS-PAGE, sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis; PtdIns(4,5)P2, phosphati- 
dylinositol4,5-bisphosphate; PtdIns4P, phosphatidylinositol4-phos- 
phate; PtdIns, phosphatidylinositol; Ins(1,4,5)P3, D-myo-inositol 
1,4,5-trisphosphate; Ins(1:2-cyclic,4,5)Pa, D-myo-inositol 1%cyclic 
4,5-trisphosphate; Ins(l,4)Pz, D-myo-inositol 1,4-bisphosphate; 
Ins(l:2-cyclic,4)P2, D-myo-inositol 1:2-cyclic, 4-bisphosphate; EGTA, 
[ethylenebis(oxyethylenenitrilo)]tetraacetic acid; DTPA, diethylene- 
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fast protein liquid chromatography; HPLC, high performance liquid 
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TABLE I 
Purification of turkey erythrocyte PLC 
PLC activity was purified from turkey erythrocyte cytosol. Enzyme activity was determined as described in the 
text. 
step Protein PLC activity 
w jimol/min 
Cytosol 1,330,000” 188 
Resuspended (NH&SO, precipitate 24,000’ 119 
Q-Sepharose 3,313* 46 
Hydroxylapatite 73.4& 24.3 
Heparin-Sepharose 18.8b 17.6 
Sephacryl S-300 3.0b 10.6 
Mono Q 1.1’ 6.9 
’ Protein was determined by calorimetric hemoglobin assay. 
* Protein was determined by the method of Bradford (29). 










cently demonstrated receptor-catalyzed tyrosine-specific 
phosphorylation (17). 
Ghosts prepared by hypotonic lysis of turkey erythrocytes 
are an excellent model cell-free system for studying P2y- 
purinergic receptor and G-protein-mediated regulation of 
PLC (18-21). None of the identified isoenzymes of PLC has 
been directly implicated in receptor-stimulated generation of 
inositol lipid-derived second messengers. Turkey erythrocytes 
offer a homogeneous and readily available source from which 
we are currently attempting to identify and purify components 
of the PLC-dependent signalling system. In this paper, we 
describe the purification and properties of a polyphosphoi- 
nositide-specific PLC from the cytosolic fraction of turkey 
erythrocytes and demonstrate differences in substrate selec- 
tivity and detergent dependence between the purified PLC 
and two mammalian PLCs of similar molecular weight. In the 
following paper, we demonstrate that, when reconstituted 
with [‘Hlinositol-labeled turkey erythrocyte ghosts, the activ- 
ity of this enzyme can be regulated by P2y-purinergic receptor 
agonists in a guanine nucleotide-dependent manner. 
EXPERIMENTAL PROCEDURES AND RESULTS* 
Results related to the purification and general catalytic 
properties of a X0-kDa PLC from turkey erythrocytes are 
presented below in Miniprint form. Table 1 summarizes re- 
sults from a typical purification. A silver-stained SDS-poly- 
acrylamide gel of fractions from a final step of Mono Q anion 
exchange chromatography and corresponding measurements 
of PLC activity for each fraction is shown in Fig. 6. On 
preliminary characterization of the enzyme, we obtained re- 
sults that were in some respects markedly different from those 
reported for two similarly sized PLC isoenzymes (PLC-p and 
-y) previously purified from bovine brain (6). We therefore 
undertook a direct comparison of the turkey erythrocyte PLC 
with PLC-fi and -7. 
Effect of Ca*+ on Turkey Erythrocyte PLC Activity 
The purified PLC was incubated with either PtdIns(4,5)P2, 
PtdInsliP, or PtdIns under standard assay conditions except 
that the free ionized calcium concentration in the incubations 
was varied using calcium EGTA buffers. For the lower values 
(0.05-0.15 mM), the actual Ca*+ concentration was measured 
in parallel incubations using the fluorescent indicator, Fura- 
’ Portions of this paper (including “Experimental Procedures” and 
certain “Results” including Figs. 1, 2, 3, 4, 5, 7, and 8 and Table 2) 
are presented in miniprint at the end of this paper. Miniprint is easily 
read with the aid of a standard magnifying glass. Full size photocopies 
are included in the microfilm edition of the Journal that is available 
from Waverly Press. 
FIG. 6. Examination of the purified PLC by SDS-PAGE. 
Fractions 50-60 from a final step of Mono Q anion exchange chro- 
matography were examined by SDS-PAGE, and proteins were de- 
tected by silver staining as described under “Experimental Proce- 
dures.” The lower panel shows PLC activity (nmol/2 ~1/5 min) 
determined in each fraction using the methods described under “Ex- 
perimental Procedures.” 
2 (33). Activity against the polyphosphoinositides was mark- 
edly dependent on Ca*+, with half-maximal activation occur- 
ring at approximately 70 nM Ca*+ with both substrates (Fig. 
9). The PLC displayed some activity in the absence of added 
Ca*+. This activity was 8% and 26% of the maximal Ca*+- 
stimulated activity observed with PtdIns4P and PtdIns- 
(4,5)P2, respectively. Under the range of assay conditions 
used, the rate of phosphatidylinositol hydrolysis observed 
with the purified PLC was at most one-hundredth of that 
displayed with the polyphosphoinositides as substrates. 
Comparison of the Turkey Erythrocyte PLC 
with PLC-/3 and PLC-7 
Ca*’ Dependence and Substrate Selectivity-The high de- 
gree of substrate selectivity observed with the 150-kDa turkey 
erythrocyte PLC differs from that observed for PLC-p and 
-y (6), although it should be noted that Katan and Parker (5) 
reported that a preparation of PLC (subsequently shown to 
be PLC-p, Ref. 11) purified from detergent extracts of bovine 
brain membranes hydrolyzed pure polyphosphoinositides 
some 30-fold faster than PtdIns. Since these earlier observa- 
tions were made using dispersions of pure inositol lipids and 
no detergent, it was important to compare directly the turkey 
erythrocyte PLC under conditions identical with those pre- 
viously used. As such, substrate was prepared as previously 
described (6) and consisted of dispersed sonicates of pure 
PtdIns or PtdIns(4,5)P2 with no detergent or other phospho- 
lipids present, each at a concentration of 0.1 mM. The activity 
of the purified turkey erythrocyte PLC was compared with 
PLC-p and -y (Fig. 10). Hydrolysis of PtdIns by all three 
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FIG. 9. Ca’+ dependence of PLC activity. The hydrolysis rates 
of PtdIns, PtdIns4P, or PtdIns(4,5)Pz by the purified PLC were 
determined as a function of Ca2+ concentration as shown using the 
methods described under “Experimental Procedures.” The incuba- 
tions contained an equal amount of the purified PLC (approximately 
100 ng). 
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FIG. 10. Ca2+ dependence of PtdIns uersus PtdIns(4,5)Pz 
hydrolysis catalyzed by the turkey erythrocyte PLC and by 
PLC-j3 and PLC-7. The hydrolysis of sonicated dispersions of 
PtdIns by the purified turkey erythrocyte PLC (ICI) and by 
PLC-fl (M) and -y (A-A) was determined at a series of 
increasing Ca*+ concentrations as described under “Experimental 
Procedures.” The rates of PtdIns(4,5)Pz hydrolysis were determined 
at a Ca2+ concentration of 10e6 M. 
PLC preparations was Ca2+-dependent. However, the maxi- 
mum specific activities displayed by PLC-B and PLC-7 
against this pure substrate were substantially greater than 
that observed with the turkey erythrocyte PLC (2.45 and 1.36 
uersuS 0.0631 pmol/min/mg, respectively). By contrast, when 
presented with pure PtdIns(4,5)PZ at an experimentally de- 
termined optimal Ca2+ concentration of 10e6 M, PLC-p, PLC- 
y, and the turkey erythrocyte PLC showed similar specific 
activities for substrate hydrolysis (3.54, 2.10, and 6.7 pmol/ 
min/mg). Similar results were obtained with PtdIns4P as 
substrate. Thus, while the two mammalian PLC isoenzymes 
hydrolyze PtdIns, PtdIns4P, and PtdIns(4,5)P2 with essen- 
tially equivalent effectiveness, the turkey erythrocyte PLC 
displays high selectivity for polyphosphoinositides over 
PtdIns. 
Effect of Sodium Cholate on PLC Actiuity-The effect of 
increasing concentrations of sodium cholate on the activity 
of purified PLC-p, PLC-7, and the turkey erythrocyte PLC 
was investigated. The substrate preparation used for these 
experiments was phospholipid vesicles composed of 
PtdIns(4,5)P2, phosphatidylserine, and phosphatidylethanol- 
amine in a molar ratio of 1:l:l prepared as described above. 
The concentration of PtdIns(4,5)PZ was 0.1 mM, and the 
concentration of Ca*+ was 10m6 M. As previously reported by 
Ryu et al. (6) using dispersions of pure PtdIns as substrate, 
the activity of PLC-p and PLC-7 sharply increased in activity 
as the concentration of detergent was increased with maximal 
activity attained at 0.05% w/v (Fig. 11). Activity declined 
rapidly at higher detergent concentrations. By contrast, no 
effect of 0.05% Na’ cholate on the turkey erythrocyte PLC 
was observed. Higher concentrations of cholate increased 
activity of the turkey erythrocyte PLC with half-maximal 
activation occurring at around 0.2% w/v and maximal activity 
attained at 0.4% w/v. The absolute magnitudes of the maxi- 
mal increases in enzymic activity observed for PLC-0, PLC- 
y, and the turkey erythrocyte PLC were similar (3.11-, 4.21-, 
and 4.42-fold, respectively). 
DISCUSSION 
A 150-kDa PLC has been purified from the cytosolic frac- 
tion of turkey erythrocytes. When assayed with exogenously 
provided substrates, the properties of this enzyme are broadly 
similar to those described for the other identified isoenzymes 
of PLC (9 and references therein). That is, activity is depend- 
ent on Ca*+ and displays an acidic pH optimum, and the 
enzyme can form both cyclic and noncyclic inositol phos- 
phates although only the latter products are detectable at 
neutral pH. The specific activity of the turkey erythrocyte 
PLC when assayed with exogenously provided polyphosphoi- 
nositide substrates is comparable to that reported for the 
other isoenzymes of PLC (9). Two isoenzymes of PLC with 
molecular weights similar to the turkey erythrocyte PLC 
(PLC-/I and PLC-r) have been purified and their cDNAs have 
been cloned (5, 6, 10, 11). In accord with published findings 
(6), we find that these isoenzymes of PLC display similar 
specific activities for hydrolysis of pure PtdIns and 
PtdIns(4,5)Pz. However, when directly compared with these 
isoenzymes of PLC under identical conditions, the turkey 
erythrocyte PLC hydrolyzes PtdIns(4,5)Pz approximately 100 
I  n 
0 PLC-8 
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n Turkey erythrocyte PLC 
! 
t-----t 
0.1 0.2 0.3 0.4 0.5 
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FIG. 11. Effect of sodium cholate on PtdIns(4,5)Pz hydrol- 
ysis catalyzed by the turkey erythrocyte PLC, PLC-8, and 
PLC-7. The effect of increasing concentrations of sodium cholate on 
the hydrolysis rate of PtdIns(4,5)Pg in mixed phospholipid vesicles 
with phosphatidylserine and phosphatidylethanolamine catalyzed by 
the purified turkey erythrocyte PLC (U) and by PLC-p 
(U) and PLC--r (A-A) was determined as described under 
“Experimental Procedures.” 
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times faster than PtdIns. Further divergence in properties 
between the 150-kDa turkey erythrocyte PLC, PLC-p, and 
PLC--y is also observed with the effect of sodium cholate on 
rates of substrate hydrolysis. Thus, when added to assay 
mixtures containing substrates in mixed phospholipid vesi- 
cles, low concentrations of sodium cholate (0.05% w/v) stim- 
ulate PLC-/3 and -y and have little effect on the turkey 
erythrocyte PLC, while stimulation of the turkey erythrocyte 
enzyme occurs with higher concentrations (>0.15% w/v) of 
detergent that are non-stimulatory or inhibitory to PLC-@ 
and PLC-7. It should be noted that, when dispersed in 
aqueous solution, the polyphosphoinositides have been ob- 
served to form micellar structures while PtdIns forms larger 
vesicular structures (4,42) so catalytic discrimination between 
substrates in these forms may represent a substrate aggrega- 
tion state preference of the PLCs rather than an absolute 
substrate selectivity. The basis of the effect of anionic bile 
salt detergents on PLC activity is also poorly understood. 
Differential effects of detergent have been noted for isoen- 
zymes of phospholipase A, and variously ascribed to differ- 
ential susceptibility to inhibition by detergent monomers, to 
differences in enzyme binding to substrate-containing deter- 
gent and phospholipid micelles, and to effects on “surface 
dilution” of substrate in the micelle (see Ref. 43 for review). 
Nevertheless, in the comparative experiments described 
above, the turkey erythrocyte PLC can be distinguished from 
PLC-fi and- y, and further studies of the structure and func- 
tion of these enzymes will be required to uncover the basis of 
this distinction. 
As an initial step in this process, by immunoblotting, we 
have found that the turkey erythrocyte PLC does not react 
with mixtures of monoclonal antibodies raised against either 
of these proteins.3 Based on a number of considerations, the 
existence of further isoenzymes of PLC with certain sequence 
similarities to, yet significant divergence from, PLC-p and -y 
is not unexpected. Ohta et al. (39) report the sequence of a 
cDNA derived from a human lymphocyte cDNA library that 
potentially encodes a protein with some homology to PLC--y. 
We have found that antibodies raised against a recombinant 
form of the protein encoded by this cDNA would not react 
with the turkey erythrocyte PLC.4 The genetic lesion of the 
Drosophila visual mutant NorpA involves a mutation of a 
gene that potentially encodes a protein with considerable 
sequence similarity to PLC-p (40). Finally, an isoenzyme of 
PLC with an estimated size of 143 kDa has been purified from 
bovine platelets (41). No information is available to suggest 
the relationship of this isoenzyme of PLC to the turkey 
erythrocyte-derived PLC or indeed to the other identified 
isoenzymes of PLC. 
Previous work from our laboratory has investigated the 
properties of a receptor- and G-protein-regulated PLC present 
in turkey erythrocyte ghosts (M-20). The substrate selectivity 
and propensity to form cyclic inositol phosphate products 
displayed by this receptor- and guanine nucleotide-activated 
PLC when acting on endogenously labeled substrates are 
similar to those of the purified PLC determined using exoge- 
nously provided substrates. However, the significance of this 
similarity is questioned by a series of original observations by 
Irvine and co-workers (35-37) made using a crude preparation 
of pig brain cytosolic PLC. Their findings established that 
the physicochemical state and phospholipid composition of 
the substrate preparation can profoundly influence the cata- 
3 G. L. Waldo, A. J. Morris, S. G. Rhee, and T. K. Harden, 
unpublished observations. 
4 J. Knopf, G. L. Waldo, A. J. Morris, and T. K. Harden, unpub- 
lished observations. 
lytic activity of PLC. In particular, PLC activity against 
phospholipids presented as components of a natural phospho- 
lipid bilayer was much reduced when compared with that 
displayed toward vesicles of pure phospholipid substrate. Un- 
der the latter assay conditions, inclusion of certain phospho- 
lipids (notably phosphatidylserine, phosphatidylethanola- 
mine, and phosphatidic acid) in the substrate-containing ves- 
icles stimulated PLC activity while phospholipids containing 
a choline head group were potent inhibitors of the enzyme. 
Similar results have been reported for one purified prepara- 
tion of PLC (38, see also Ref. 9 for review) and further studies 
on the effect of substrate phospholipid composition on the 
activity of the 150-kDa turkey erythrocyte PLC are clearly 
warranted. In broad agreement with the results discussed 
above, we note that although it shows high activity against 
substrates presented as mixed phospholipid and detergent 
micelles, the turkey erythrocyte PLC is considerably less 
active when incubated with turkey erythrocyte ghosts con- 
taining radiolabeled substrates. However, under appropriate 
conditions, we have found that hormonal activators can stim- 
ulate the purified turkey erythrocyte PLC to hydrolyze poly- 
phosphoinositide components of turkey erythrocyte ghost 
membranes, and this phenomenon is discussed in the follow- 
ing paper (44). 
In summary, further work is required to establish the rela- 
tionship of the turkey erythrocyte PLC to the other members 
of the family of PLC isoenzymes. The generation of antibodies 
directed against the turkey erythrocyte PLC and ultimately 
molecular cloning and the determination of its primary se- 
quence will be important steps in this process. 
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